Stock listing
Hamlet Biopharma Ab Class B
Selected listing: A3CMH3 · LSX · EUR · DE
Hamlet Biopharma Ab Class B (LS Exchange: A3CMH3), Health Technology. Latest release Feb 23, 2026: Acres.com and Hamlet Partner to Bring Local Government…
- Ticker
- LS Exchange: A3CMH3
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS Exchange
- Currency
- EUR
About Hamlet Biopharma Ab Class B
The company focuses on developing innovative biopharmaceuticals. Its research and development efforts aim to address significant medical needs through advanced therapeutic solutions.
Latest news from Hamlet Biopharma Ab Class B
Acres.com and Hamlet Partner to Bring Local Government Sentiment Data to Land Intelligence
February 23, 2026
Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer
August 21, 2025
Hamlet BioPharma Holds Successful In Person Meeting with US FDA
June 25, 2025
Research Hamlet Biopharma Ab Class B
Hamlet Biopharma Ab Class B company profile
View the public company page for Hamlet Biopharma Ab Class B on 6ix.
Hamlet Biopharma Ab Class B news
Read company news and market updates connected to Hamlet Biopharma Ab Class B.
Hamlet Biopharma Ab Class B investor events
Find investor webinars, events, and replay context for Hamlet Biopharma Ab Class B.
Alternate listings
HAMLET.B:NGM
SE · SEK
Alternate listing for Hamlet Biopharma Ab Class B; the primary context on this page is A3CMH3:LSX.
A3CMH3:LS
DE · EUR
Alternate listing for Hamlet Biopharma Ab Class B; the primary context on this page is A3CMH3:LSX.
7ZT:SWB
DE · EUR
Alternate listing for Hamlet Biopharma Ab Class B; the primary context on this page is A3CMH3:LSX.
7ZT:FWB
DE · EUR
Alternate listing for Hamlet Biopharma Ab Class B; the primary context on this page is A3CMH3:LSX.